Faeth goes public in merger with Sensei, nets $200M in stock salenews2026-02-18T13:00:57+00:00February 18th, 2026|Endpoints News|
FDA reverses course, will review Moderna’s flu vaccinenews2026-02-18T12:45:45+00:00February 18th, 2026|Endpoints News|
NeuExcell Therapeutics’ brain cancer therapy tests debated fieldnews2026-02-18T12:00:07+00:00February 18th, 2026|Endpoints News|
Lilly licenses CSL’s IL-6 immuno-inflammatory antibody for $100M upfrontnews2026-02-18T11:31:31+00:00February 18th, 2026|Endpoints News|
Paragon’s new biotech Korsana tackles Alzheimer’s like Rochenews2026-02-18T11:00:57+00:00February 18th, 2026|Endpoints News|
Leo Pharma says it’s turned a profit for the first time in seven yearsnews2026-02-18T08:00:28+00:00February 18th, 2026|Endpoints News|
Moderna faces setback in Arbutus’ mRNA patent fightnews2026-02-17T20:36:05+00:00February 17th, 2026|Endpoints News|
FDA rejects Disc Medicine’s rare disease drug despite granting it a commissioner vouchernews2026-02-17T16:14:16+00:00February 17th, 2026|Endpoints News|
Six biotechs file for HKEX listing; Faraday Pharmaceuticals shuttersnews2026-02-17T15:52:53+00:00February 17th, 2026|Endpoints News|
